Purchase Order 75N93022P01069
- Not listed
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business and manufacturer of goods, for an optofluidic platform and related consumables. The $219,426.90 contract is to provide an essential service agreement for the NIAID Beacon Optofluidic System, which is utilized by the NIAID's Laboratory...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, awarded a $114,750.00 firm fixed-price purchase order contract to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business manufacturer located in Emeryville, California. The contract, titled "BEACON ESSENTIAL SERVICE PLAN," has a completion date of June 29, 2026. The contract does not have a set-aside designation. Bruker Cellular Analysis, Inc....
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $110,000.00 firm fixed price purchase order to Bruker Cellular Analysis, Inc. for an annual maintenance and service plan for the NIAID's Beacon optofluidic system. This system is a critical tool used by NIAID's Antibody Biology Unit to support COVID-19 research and the identification of monoclonal antibodies against SARS-CoV-2. The award was made on a sole source basis under the...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business manufacturer of goods located in Emeryville, California. The $14,145.01 contract is for the provision of laboratory consumables, specifically "Single-Cell Secretome Adaptive Immune Chips (Human)". The contract has an ultimate completion date of October 25, 2025 and was awarded on September 26,...
- This federal contract award to Bruker Cellular Analysis, Inc. for $331,949.00 was issued by the Department of Health and Human Services' National Institutes of Health, specifically the National Institute of Allergy and Infectious Diseases. The contract is for the provision of an optofluidic platform and related consumables to enable single cell analysis, which is being utilized for antibody discovery and development against SARS-CoV-2 in response to the COVID-19 pandemic. The contract is a...
- Bruker Cellular Analysis, Inc. was awarded a $367,763 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide optofluidic platform consumables for antibody discovery in support of COVID-19 response efforts. As part of its mission to accelerate and expand biomedical research on infectious diseases, the NIH-NIAID is utilizing Bruker's single-cell analysis technology and consumables to facilitate rapid antibody...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded a $14,654 firm fixed price purchase order contract to Bruker Cellular Analysis, Inc. for the delivery of OPTOSELECT CHIPS. Bruker Cellular Analysis is a small disadvantaged business that manufactures optofluidic platforms and related consumables for single cell analysis. This award supports NIAID's efforts to combat the COVID-19 pandemic, with the chips being...
- This is a $34,400.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business manufacturer of goods. The contract is for an ISOSPARK DUO SERVICE AGREEMENT and does not have a set-aside designation. The contract supports Bruker's provision of advanced laboratory equipment, consumables, and services, with a focus on supporting COVID-19 related research and...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.5 million firm fixed-price purchase order to Bruker Cellular Analysis, Inc. to deliver an optofluidic platform for antibody discovery in support of COVID-19 response efforts. As a division of Bruker Cellular Analysis, Inc. located in Oakland, California, the prime contractor will provide the requested products and services from its place of performance in Oakland. The contract supports...
- This is a $79,486.17 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson & Co (BD) for the upgrade of BD's FACSCelesta SORP flow cytometer system. The upgrade includes the addition of a small particle side scatter detector and a high throughput sampler, which will enhance NIAID's Laboratory of Immunoregulation's research capabilities in understanding the pandemic...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bruker Cellular Analysis, Inc., a small disadvantaged business manufacturer, for consumables compatible with the Beacon Optofluidic System. The contract has a total ceiling value of $88,292.85 and a period of performance ending on July 30, 2023. The contract was awarded on August 30, 2022 on an other than full and open competition basis under the authority of 41 U.S.C. 1901(a)(1), as Berkeley Lights, Inc. was determined to be the only responsible source. No set-aside designation was used. The consumables procured under this contract support NIAID's research and development efforts related to COVID-19, including antibody discovery and development.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Consumables Beacon Optofluidic System | NOI-NIAID-2136901 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 8/15/22, 6:37 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $88.3k | 8/30/22 |